Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endometrial cancer
develops as a result of abnormal cell growth associated with uncontrolled cell proliferation, excessive activation of signaling pathways and miRNA activity. The aim of this study was to determine the expression profile of genes associated with cell proliferation and to assess which miRNAs can participate in the regulation of their expression. The study enrolled 40 patients with
endometrial cancer
and 10 patients without neoplastic changes. The expression profile of genes associated with cell proliferation and the expression profile of miRNAs were assessed using microarrays. RT-qPCR was performed to validate mRNA microarray results. The mirTAR tool was used to identify miRNAs that regulate the activity of genes associated with cell proliferation. Decreased expression of
IGF1
and
MYLK
, as well as
SOD2
overexpression, were observed in
endometrial cancer
using both mRNA microarrays and RT-qPCR. Microarray analysis showed low levels of
NES
and
PRKCA
, but this was only partially validated using RT-qPCR. Reduced activity of
MYLK
may be caused by increased miR-200c, miR-155 and miR-200b expression. Cell proliferation is disturbed in
endometrial cancer
, which may be associated with an overexpression of miR-200a, miR-200c, and miR-155, making it a potential diagnostic marker.
...
PMID:Interplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial Cancer. 3179 19